Get quotes from auditors in Hodgkins


  • Save money on your audit job
  • Top auditors in Hodgkins
  • Free and non-binding quotes


I alt 0 revisorfirmaer fundet i Hodgkins.

An audit of compliance with the BCSH guideline on the first line

An audit of compliance with the BCSH guideline on the first line management of classical Hodgkin lymphoma (cHL). Haematology · Audit templates. April 2016.

An audit of compliance with the BCSH guidelines for the

An audit of compliance with the BCSH guidelines for the management of adults' relapsed and refractory Hodgkin's lymphoma. Haematology · Audit templates.

First Line Management of Classical Hodgkin lymphoma | British

9 Apr 2014 · The treatment of patients with relapsed or refractory Hodgkin lymphoma is addressed in a separate guideline. Go to full guideline Download audit 

Investigation and Management of Nodular Lymphocyte Predominant

5 Nov 2015 · of patients of all ages with nodular lymphocyte predominant Hodgkin lymphoma including: Go to full guideline Download audit template.

Tools and resources | Non-Hodgkin's lymphoma: diagnosis and

20 Jul 2016 · This guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over Audit and service improvement.

[PDF] national institute for clinical excellence - NICE

Rituximab for aggressive non-Hodgkin's lymphoma. Issue date: July be used. Further details on suggestions for audit are presented in Appendix C. 7.3.1 An 

[PDF] Lymphoma QPIs - North Region Health & Care Collaboration

28 Oct 2019 · Non-Hodgkin's lymphoma is the seventh most common cancer type in A total of 288 cases of lymphoma were recorded through audit as 

An audit of patients with mature T-cell non-Hodgkin lymphoma by

This retrospective audit of patients diagnosed with mature T-cell lymphoma across a 10-year period provides contemporary information on the outcomes and​ 

Retrospective audit of clinico-pathologic features and treatment

Introduction: There is limited data from India regarding elderly non-Hodgkin's lymphomas (NHL) patients. Hence, this audit was planned to study the 

Haematological malignancies: Hodgkin lymphoma in the second

ESMO-EHA clinical practice guidelines for the management of malignant lymphoma – recommendations for the second phase of the COVID-19 pandemic:​